According to Shinpoong Pharm's latest financial reports the company's current EPS (TTM) is -HK$4.79. In 2022 the company made an earnings per share (EPS) of -HK$4.14 a decrease over its 2021 EPS that were of -HK$1.47.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$4.83 | 16.55% |
2022 | -HK$4.14 | 182.43% |
2021 | -HK$1.47 | -326.47% |
2020 | HK$0.65 | -8.85% |
2019 | HK$0.71 | 75.6% |
2018 | HK$0.40 | 269.67% |
2017 | HK$0.11 | -103.94% |
2016 | -HK$2.78 | -1436.05% |
2015 | HK$0.21 | -71.86% |
2014 | HK$0.74 | -29.56% |
2013 | HK$1.05 | -24.55% |
2012 | HK$1.39 | -68.07% |
2011 | HK$4.36 | 22.65% |
2010 | HK$3.55 | 11.53% |
2009 | HK$3.19 | 55.55% |
2008 | HK$2.05 | 19.44% |
2007 | HK$1.71 |